Opening book details…
About this Medicine article
122 ERCC1-negative tumors benefit from neoadjuvant cisplatin-based chemotherapy whereas patients with ERCC1-positive tumors do not – results from a cystectomy trial database by Hemdan, T.; Segersten, U.; Malmström, P-U. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Hemdan, T.; Segersten, U.; Malmström, P-U.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 1569-9056)
- Published
- 2014
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Hemdan, T.; Segersten, U.; Malmström, P-U.
Browse all works by Hemdan, T.; Segersten, U.; Malmström, P-U.